ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 14 Aug 2023
Last Updated on 14 Aug 2023
A- A+
Guidance Recommendation

The Ministry of Health’s Medical Technology Advisory Committee has not recommended subsidy for SpaceOAR systems (SpaceOAR and SpaceOAR Vue Systems) for rectum protection during prostate cancer treatment.

Funding status

SpaceOAR systems are not recommended for subsidy in patients with the abovementioned indications.




SpaceOAR systems for rectum protection during prostate cancer treatment